Treadmill exercise in claudicants on aspirin results in improved antioxidant status but only minimal platelet activation

Platelets

Volumn 16, Issue 8, 2005, Pages 446-452

  Cleanthis, M ^a   Smout, J ^b   Bhattacharya, V ^a   Ashour, H ^a   Shenton, B ^c   Stansby, G ^b  

^a QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Antioxidant status; Aspirin; Exercise; Peripheral arterial disease; Platelet activation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT; FIBRINOGEN RECEPTOR; PADGEM PROTEIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLAUDICATION; CLINICAL ARTICLE; DECOLORIZATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; TREADMILL EXERCISE;

AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASPIRIN; CASE-CONTROL STUDIES; EXERCISE TEST; FEMALE; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; OXIDATION-REDUCTION; P-SELECTIN; PHENOLS; PLANT EXTRACTS; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; REPERFUSION INJURY;

EID: 30944433375     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500128740     Document Type: Article

References (52)

1. Burek K, Sutton-Tyrrell K, Brooks M, Naydeck B, Keller N, Sellers M, Roubin G, Jandova R, Rihal C. Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation. J Am Coll Cardiol 1999;34:716-721.
2. Regensteiner JG, Hiatt WR. Current medical therapies for patients with peripheral arterial disease: A critical review. Am J Med 2002;112:49-57.
3. Degischer S, Labs KH, Hochstrasser J, Aschwanden M, Tschoepl M, Jaeger KA. Physical training for intermittent claudication: A comparison of structured rehabilitation versus home-based training. Vasc Med 2002;7:109-115.
4. Shearman CP, Gosling P, Gwynn BR, Simms MH. Systemic effects associated with intermittent claudication. A model to study biochemical aspects of vascular disease. Eur J Vasc Sur 1988;2:401-404.
5. Robless P, Okonko D, Lintott P, Mansfield A, Mikhailidis D, Stansby G. Increased Platelet aggregation and activation in peripheral arterial disease. Eur J Vasc Endovasc Surg 2003;25:16-22.
6. Cassar K, Bachoo P, Ford I, Greaves M, Brittenden J. Platelet activation is increased in peripheral arterial disease. J Vasc Surg 2003;38:99-103.
7. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998;31:352-358.
8. Freedman JE, Loscalzo J. Platelet-monocyte aggregates: Bridging thrombosis and inflammation. Circulation 2002;105:2130-2132.
9. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger AL, 3rd, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001;38:1002-1006.
10. Gawaz M, Fateh-Moghadam S, Pilz G, Gurland HJ, Werdan K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 1995;25:843-851.
11. Smout JD, Mikhailidis DP, Shenton BK, Stansby G. Combination antiplatelet therapy in patients with peripheral vascular bypass grafts. Clin Appl Thromb Hemost 2004;10:9-18.
12. Miller NJ, Rice-Evans C, Davies V, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993;84:407-412.
13. Khaira HS, Nash GB, Bahra PS, Sanghera K, Gosling P, Crow AJ, Shearman CP. Thromboxane and neutrophil changes following intermittent claudication suggest ischaemia-reperfusion injury. Eur J Vasc Endovasc Surg 1995;10:31-35.
14. Wang JS, Jen CJ, Kung HC, Lin LJ, Hsiue TR, Chen HI. Different effects of strenuous exercise and moderate exercise on platelet function in men. Circulation 1994;90:2877-2885.
15. Cuzzolin L, Lussignoli S, Crivellente F, Adami A, Schena F, Bellavite P, Brocco G, Benoni G. Influence of an acute exercise on neutrophil and platelet adhesion, nitric oxide plasma metabolites in inactive and active subjects. Int J Sports Med 2000;21:289-293.
16. Cadroy Y, Pillard F, Sakariassen KS, Thalamas C, Boneu B, Riviere D. Strenuous but not moderate exercise increases the thrombotic tendency in healthy sedentary male volunteers. J Appl Physiol 2002;93:829.
17. Naesh O, Hindberg I, Trap-Jensen J, Lund JO. Post-exercise platelet activation, aggregation and release in relation to dynamic exercise. Clin Physiol 1990;10:221-230.
18. Hurlen M, Seljeflot I, Arnesen H. Increased platelet aggregability during exercise in patients with previous myocardial infarction. Lack of inhibition by aspirin. Thromb Res 2000;99:487-494.
19. Andreotti F, Lanza GA, Sciahbasi A, Fischetti D, Sestito A, De Cristofaro R, Maseri A. Low-grade exercise enhances platelet aggregability in patients with obstructive coronary disease independently of myocardial ischemia. Am J Cardiol 2001;87:16-20.
20. Winther K, Rein E. Exercise-induced platelet aggregation in angina and its possible prevention by beta 1-selective blockade. Eur Heart J 1990;11:819-823.
21. Douste-Blazy P, Sie P, Boneu B, Marco J, Eche N, Bernadet P. Exercise-induced platelet activation in myocardial infarction survivors with normal coronary arteriogram. Thromb Haemost 1984;52:297-300.
22. Gallino A, Haberli A, Straub PW, Steinbrunn W, Turina M, Rothlin MF.. Does exercise-induced myocardial ischaemia cause enhanced platelet activation and fibrin formation in patients with stable angina and severe coronary artery disease? Eur Heart J 1987;8:734-737.
23. Lindemann S, Klingel B, Fisch A, Meyer J, Darius H. Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease. Thromb Res 1999;93:51-59.
24. Green LH, Seroppian E, Handin RI. Platelet activation during exercise-induced myocardial ischemia. New Engl J Med 1980;302:193-197.
25. Kirkpatrick UJ, Mossa M, Blann AD, McCollum CN. Repeated exercise induces release of soluble P-selectin in patients with intermittent claudication. Thromb Haemost 1997;78:1338-1342.
26. Pasqualini L, Pirro M, Lombardini R, Ciuffetti G, Dragani P, Mannarino E. A human model of platelet-leucocyte adhesive interactions during controlled ischaemia in patients with peripheral vascular disease. J Clin Pathol 2002;55:946-950.
27. Constans J, Segneur M, Blann AD, Lestage B, Resplandy F, Renard M, Chaudet B, Amiral J, Guerin V, Biosseau MR, Conri C. Endothelial function, platelet activation and coagulation in lower limb occlusive arterial disease during treadmill exercise. Thromb Res 2000;99:557-561.
28. Hilberg T, Eichler E, Glaser D, Schmidt V, Gabriel HW. Platelet activity, reactivity and platelet-leukocyte conjugate formation before and after exhaustive or moderate exercise in patients with IDDM. Platelets 2004;15:101-108.
29. Hu H, Johansson BL, Li N. Exercise-induced platelet and leucocyte activation is not enhanced in well controlled Type 1 diabetes, despite increased activity at rest. Diabetologia 2004;47:853-859.
30. Baele G, Bogaerts H, Clement DL, Pannier R, Barbier F. Platelet activation during treadmill exercise in patients with chronic peripheral arterial disease. Thromb Res 1981;23:215-223.
31. Edwards AT, Blann AD, Suarez-Mendez VJ, Lardi AM, McCollum CN. Systemic responses in patients with intermittent claudication after treadmill exercise. Br J Surg 1994;81:1738-1741.
32. Lewis DR, Day A, Jeremy JY, Newcombe PV, Brookes ST, Baird R, Smith FC, Lamont PM. Vascular surgical society of Great Britain and Ireland: Systemic effects of exercise in claudicants are associated with neutrophil activation. Br J Surg 1999;86:699-700.
33. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533-1537.
34. Rohrer MJ, Claytor RB, Garnette CS, Powell CC, Barnard MR, Furman MI, Michelson AD. Platelet-monocyte aggregates in patients with chronic venous insufficiency remain elevated following correction of reflux. Cardiovasc Surg 2002;10:464-469.
35. Hilberg T, Gla D, Schmidt V, Losche W, Franke G, Schneider K, Gabriel HH. Short-term exercise and platelet activity, sensitivity to agonist, and platelet-leukocyte conjugate formation. Platelets 2003;14:67-74.
36. Mockel M, Ulrich NV, Heller G, Jr., Rocker L, Hansen R, Riess H, Patscheke H, Stork T, Frei U, Ruf A. Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med 2001;22:337-343.
37. Li N, Wallen NH, Hjemdahl P. Evidence for prothrombotic effects of exercise and limited protection by aspirin. Circulation 1999;100:1374-1379.
38. Klinkhardt U, Bauersachs R, Adams J, Graff J, Lindhoff-Last E, Harder S. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease. Clin Pharmacol Ther 2003;73:232-241.
39. Buczynski A, Kedziora J, Tkaczewski W, Wachowicz B. Effect of submaximal physical exercise on antioxidative protection of human blood platelets. Int J Sports Med 1991;12:52-54.
40. Kedziora J, Buczynski A, Kedziora-Kornatowska K. Effect of physical exercise on antioxidative enzymatic defence in blood platelets from healthy men. Int J Occup Med Environ Health 1995;8(1):33-39.
41. Tozzi-Ciancarelli MG, Penco M, Di Massimo C. Influence of acute exercise on human platelet responsiveness: Possible involvement of exercise-induced oxidative stress. Eur J Appl Physiol 2002;86:266-272.
42. Andican G, Koldas L, Seven A, Ayan F, Sirmaci N, Burcak G. Biochemical evaluation of oxidative stress during exercise in patients with coronary heart disease. Clin Chem Lab Med 2001;39:234-238.
43. Khaira HS, Maxwell SR, Shearman CP. Antioxidant consumption during exercise in intermittent claudication. Br J Surg 1995;82:1660-1662.
44. Lewis DR, Day A, Jeremy JY, Baird RN, Smith FC, Lamont PM. The systemic effects of intermittent claudication are reversed by angioplasty. Eur J Vasc Endovasc Surg 2001;22:326-330.
45. Hickman P, Harrison DK, Hill A, McLaren M, Tamei H, McCollum PT, Belch JJ. Exercise in patients with intermittent claudication results in the generation of oxygen derived free radicals and endothelial damage. Adv Exp Med Biol 1994;361:565-570.
46. Christiaens L, Macchi L, Herpin D, Coisne D, Duplantier C, Allal J, Mauco G, Brizard A. Resistance to aspirin in vitro at rest and during exercise in patients with angiographically proven coronary artery disease. Thromb Res 2002;108:115-119.
47. Barradas MA, Stansby G, Hamilton G, Mikhailidis DP. Effect of naftidrofuryl and aspirin on platelet aggregation in peripheral vascular disease. In Vivo 1993;7:543-548.
48. Peripheral Arterial Diseases Antiplatelet Consensus Group. Antiplatelet therapy in peripheral arterial disease. Consensus statement. Eur J Vasc Endovasc Surg 2003;26:1-16.
49. Robless P, Mikhailidis DP, Stansby G. Systematic review of antiplatelet therapy for the prevention of myocardial infarction, stroke or vascular death in patients with peripheral vascular disease. Br J Surg 2001;88:787-800.
50. Ristimae T, Zilmer M, Zilmer K, Kairane C, Kullisaar T, Teesalu R. Effect of low-dose aspirin on the markers of oxidative stress. Cardiovasc Drugs Ther 1999;13:485-490.
51. Watts EJ. Haemostatic changes in long-distance runners and their relevance to the prevention of ischaemic heart disease. Blood Coagul Fibrinolysis 1991;2:221-225.
52. Powers SK, Ji LL, Leeuwenburgh C. Exercise training-induced alterations in skeletal muscle antioxidant capacity: A brief review. Med Sci Sports Exerc 1999;31:987-997.